Cas:1872364-25-4 7H-Benzo[b]fluoreno[3,4-d]furan, 5,9-dibromo-7,7-diphenyl- manufacturer & supplier

We serve Chemical Name:7H-Benzo[b]fluoreno[3,4-d]furan, 5,9-dibromo-7,7-diphenyl- CAS:1872364-25-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

7H-Benzo[b]fluoreno[3,4-d]furan, 5,9-dibromo-7,7-diphenyl-

Chemical Name:7H-Benzo[b]fluoreno[3,4-d]furan, 5,9-dibromo-7,7-diphenyl-
CAS.NO:1872364-25-4
Synonyms:7H-Benzo[b]fluoreno[3,4-d]furan, 5,9-dibromo-7,7-diphenyl-
Molecular Formula:N/A
Molecular Weight:N/A
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 7H-Benzo[b]fluoreno[3,4-d]furan, 5,9-dibromo-7,7-diphenyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,7H-Benzo[b]fluoreno[3,4-d]furan, 5,9-dibromo-7,7-diphenyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,7H-Benzo[b]fluoreno[3,4-d]furan, 5,9-dibromo-7,7-diphenyl- Use and application,7H-Benzo[b]fluoreno[3,4-d]furan, 5,9-dibromo-7,7-diphenyl- technical grade,usp/ep/jp grade.


Related News: China is now dealing with another disease outbreak �� this one mostly affecting animals but also potentially deadly among people. 7H-Benzo[b]fluoreno[3,4-d]furan, 5,9-dibromo-7,7-diphenyl- manufacturer At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world. 7H-Benzo[b]fluoreno[3,4-d]furan, 5,9-dibromo-7,7-diphenyl- supplier INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment. 7H-Benzo[b]fluoreno[3,4-d]furan, 5,9-dibromo-7,7-diphenyl- vendor GlaxoSmithKline��s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection. 7H-Benzo[b]fluoreno[3,4-d]furan, 5,9-dibromo-7,7-diphenyl- factory China is now dealing with another disease outbreak �� this one mostly affecting animals but also potentially deadly among people.